Book a demo

Chemical intelligence powered by cypris.ai

FMN-Na

sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate;dihydrate · also: Photrexa, flavin mononucleotide, Phosphated riboflavin, riboflavin sodium phosphate, Sodium Riboflavin Phosphate, Flavin mononucleotide dihydrate

FormulaC17H24N4NaO11P
Mol. weight514.3595
PubChem CID23687712
InChIKeyLQVGUKOCMOKKJU-QPVGXXQTSA-M
SMILESCC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](COP(=O)(O)[O-])O)O)O.O.O.[Na+]
121Patents
3,116Research papers
32Patents - last 3 years
89Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Eisai R&D Management Co Ltd13
2Rohto Pharmaceutical Co Ltd12
3Avedro Inc7
4Imperial Tobacco Ltd Great Britain7
5Ajinomoto Co Inc6
6Resonac Holdings Corp6
7Daiichi Sankyo Healthcare Co Ltd4
8Eisai Co Ltd4
9Hisamitsu Pharmaceutical Co Inc4
10Chelsea Technologies Ltd3

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations54
2A61PTherapeutic activity (drug indications)42
3C07DHeterocyclic compounds24
4A23LFoods and beverages (general)12
5G01NInvestigating / analysing materials12
6A23VFoods, foodstuffs - indexing scheme11
7A61N8
8A61QCosmetics, personal care8
9A01NPreservation of bodies; biocides; pest repellents6
10A24B6

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Most-cited patents

Patents ranked by forward citations reveal the foundational inventions the field continues to build on.

TitleYearAssigneeCited by
Riboflavin sodium phosphate freeze-dried powder injection and preparation method thereof2011HAINAN LEVTEC PHARMACEUTICAL CO., LTD.0

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1bioluminescence and chemiluminescence research11
2Photosynthetic Processes and Mechanisms8
3Amino Acid Enzymes and Metabolism7
4Pharmacogenetics and Drug Metabolism6
5Enzyme Structure and Function5
6Metabolism and Genetic Disorders4
7Nitric Oxide and Endothelin Effects4
8Light effects on plants3
9Molecular Sensors and Ion Detection3
10Polyamine Metabolism and Applications3

Technology trend analysis

Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.

See Cypris in action

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Gordon TollinUniversity of Arizona37
2Stephen G. MayhewUniversity College Dublin35
3Adelbert BacherTechnical University of Munich25
4Vincent MasseyUniversity of Michigan21
5J. Woodland HastingsHarvard University20
6Nigel S. ScruttonUniversity of Manchester18
7Changjian FengUniversity of New Mexico17
8Donald B. McCormickCornell University16
9Franz MüllerGraduate School Experimental Plant Sciences14
10Andrew W. MunroUniversity of Strathclyde12

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular composition and structure of FMN-Na?

FMN-Na has the molecular formula C17H24N4NaO11P and a molecular weight of 514.3595. Its canonical name is sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate;dihydrate. The compound is also known by several synonyms including Photrexa, flavin mononucleotide, phosphated riboflavin, and sodium riboflavin phosphate.

What is the patent activity landscape for FMN-Na?

FMN-Na has a total of 121 patents in the aggregate, with 32 patents filed in the last three years. Patent activity shows an upward trend, with 13 patents filed in 2025, 11 in 2024, and 10 in 2022. The leading patent assignees are Eisai R&D Management Co Ltd with 13 patents and Rohto Pharmaceutical Co Ltd with 12 patents. The primary patent classification areas are A61K (54 patents), A61P (42 patents), and C07D (24 patents).

What research topics dominate the scientific literature on FMN-Na?

FMN-Na is most prominently studied in bioluminescence and chemiluminescence research, with 10 papers on this topic. Other significant research areas include Photosynthetic Processes and Mechanisms (7 papers), Amino Acid Enzymes and Metabolism (6 papers), and Pharmacogenetics and Drug Metabolism (6 papers). Enzyme Structure and Function research accounts for 5 papers.

Who are the leading researchers publishing on FMN-Na?

Gordon Tollin from the University of Arizona is the most prolific author with 37 papers on FMN-Na, followed by Stephen G. Mayhew from University College Dublin with 35 papers. Adelbert Bacher from Technical University of Munich has published 25 papers, Vincent Massey from University of Michigan has 21 papers, and J. Woodland Hastings from Harvard University has 20 papers on the compound.

What is the overall research coverage for FMN-Na?

The aggregate includes 3116 papers related to FMN-Na through journal and publication joins, with 3096 confirmed matches through direct searches. In the past three years, 89 papers have been published on the compound. Historical coverage shows peak paper publication in 2019 with 65 papers, with consistent research activity ranging from 30 to 65 papers annually from 2016 to 2024.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial